The Board of Directors consists of elected members of the Society. Meeting at least once annually, it is entrusted with the corporate governance and overall management of the ISBT. The Board sets the strategic direction of the Society. Its general and financial responsibilities are detailed in the Statutes. All permanent and ad hoc ISBT committees and working parties are appointed by the Board. The Board determines when and where international and regional congresses are to be held. The ISBT Board delegates specific management and administrative functions to the Executive Committee, who are all members of the Board. This committee in turn, works to ensure that the Society acts in accordance with Board decisions and with resolutions of the General Assembly.
The ISBT Board of Directors is composed of the members of the Executive Committee, together with nine Regional Directors. The Statutes designate that the Executive Committee is composed of the President, President Elect, Past President, Vice Presidents, Secretary General and the Treasurer.
Erica Wood is the president of ISBT, and a member of its working parties on clinical practice, haemovigilance, and transfusion-transmitted infectious diseases. From 2010-2014 she was ISBT regional director for the Western Pacific region. Erica is head of the Transfusion Research Unit in the Department of Epidemiology and Preventive Medicine at Monash University in Melbourne, Australia. She is a consultant haematologist at Monash Health and holds an honorary appointment at the Peter MacCallum Cancer Centre. Erica is president of the International Haemovigilance Network, past-president of the Australian and New Zealand Society of Blood Transfusion, and a member of the World Health Organization Expert Advisory Panel in Transfusion Medicine. Erica has served as Chief Examiner (Haematology) for the Royal College of Pathologists of Australasia and chair of the Joint Specialist Advisory Committee in Haematology. She is a member of the Victorian Blood Matters program advisory committee and the expert group of its Serious Transfusion Incident Reporting (STIR) haemovigilance program. In 2013, Erica was awarded a Churchill Fellowship to support her practice and research in patient blood management.
Michael Busch earned his MD and PhD degrees at the University of Southern California followed by residency training in Pathology, Laboratory Medicine and Transfusion Medicine at the University of California, San Francisco (UCSF). He is currently Director of Vitalant Research Institute (VRI) and Senior Vice President for Research and Scientific Affairs at Vitalant, a national network of blood centers and donor testing laboratories. He is also a Professor of Laboratory Medicine at UCSF. Michael is one of the world’s leading transfusion medicine scientists, well-regarded for his ground-breaking work in such transfusion-transmitted diseases as HIV, HBV, HCV, HTLV and West Nile virus and protection of the nation’s blood supply from these and other emerging pathogens including ZIKV and SARS-CoV-2. He has published over 550 peer-reviewed scientific articles, editorials and book chapters. Michael is a member of the Transfusion Transmitted Diseases Committee of AABB, the Research and Development Advisory Committee of Canadian Blood Services and several World Health Organization panels.
Masja de Haas (MD, PhD) is vice-president of Sanquin Diagnostic Services (Amsterdam) and professor in Immunohaematology (University of Leiden), in the Netherlands. She has now over 20 years of experience in transfusion medicine. Her research interests are auto-and alloimmune-mediated blood cell destruction. This extends to the evaluation and design of optimal diagnostic and treatment strategies, such as transfusion policies. She is a member of the ISBT Working Parties for Red Cell Immunogenetics and Blood Group Terminology and Rare donors, respectively. She aims to contribute to the ISBT community by supporting the dissemination of knowledge to strengthen transfusion medicine worldwide.
Lin Fung is the Associate Professor in Medical Laboratory Science at the University of the Sunshine Coast. She has worked in tertiary hospital pathology laboratories, led research teams at the Australian Blood Service and University of Queensland, and was the Chair of the ISBT Granulocyte Immunobiology Working Party. She serves on two hospital blood management committees and has an active interest in translational transfusion research. This led her to set up the OptiBlood research team, which runs studies directed at optimising the patient’s blood and use of blood products. Lin enjoys public speaking, facilitating collaborations, mentoring young scientists and is an advocate for evidence based transfusion practice.
Martin L. Olsson is a full Professor of Transfusion Medicine since 2006 and also the Vice Dean of the Faculty of Medicine (2018- ) at Lund University in Sweden. He received his M.D. (1991) and Ph.D. (1997) in Lund where he also heads up a large research group on red blood cell biology. Since 2001, he is the Medical Director of the Nordic Blood Group Reference Laboratory, part of healthcare in Region Skåne, Sweden. He was a Visiting Scientist at IBGRL/BITS in Bristol, UK (1996) and a Visiting Associate Professor/Lecturer at Harvard Medical School (2003-2008). His main clinical and research interests involve the biochemistry, genetics and function of red cell surface molecules with a special emphasis on their roles in hemolysis, hematopoiesis and hemostasis. Prof. Olsson has received numerous awards from different organisations including ISBT, BBTS and AABB and is currently a Wallenberg Clinical Scholar (2015-2020), appointed by Knut and Alice Wallenberg Foundation after selection by the Royal Swedish Academy of Sciences. He previously served on the ISBT Board as Regional Director for Western Europe (2006-2008) and was ISBT’s first Scientific Secretary (2011-2015).
Gwen Clarke is a physician with training at the University of Alberta and at Emory University. She has clinical and research interests in perinatal immunohematology and experience as a hospital transfusion medicine physician and with the Canadian blood supplier. Her current role with Canadian Blood services includes medical leadership for perinatal and immunohematology reference laboratories, consultation in donor testing and for the Rare Blood Program. Gwen is a Clinical Professor in the Department of Laboratory Medicine at the University of Alberta. She is a former program director for residency training in Hematopathology and an examiner for the Royal College of Physicians and Surgeons of Canada. Gwen has recently completed a term as president of the Canadian Society for Transfusion Medicine.
Eric Jansen is currently working as an independent consultant in Blood Supply Chain Management. He is partner together with prof. dr. ir. Jan van der Wal in the company Blood Supply Chain Solutions. Eric retired in 2013 from his role as managing director of the Sanquin Blood Service Amsterdam in the Netherlands. Together with Steve Morgan he started and chaired the EBA Benchmarking project, aiming at performance improvement. Best practice are identified and via the EBA Flying Squad members in Europe (and US) were helped in the implementation of these best practices. Eric Jansen also worked in University and general hospitals in the Netherlands.
Nine Regional Directors are elected to represent the WHO regions. They determine the strategic direction of the Society and provide guidance on relevant issues, they promote the Society and the ISBT Academy and they act as a link between the ISBT and National and Regional Societies.
Shirley Owusu-Ofori is currently Head of Transfusion Medicine Unit of the Komfo Anokye Teaching Hospital and Acting Director of Central Zonal Blood Center in Kumasi, Ghana. Her research interests span across blood donor care, voluntary donor activity and blood safety in resource-constrained economies. She is a member of the ISBT Academy Advisory Committee and Science Series Editorial Board. Shirley has been runner up for ISBT Award for Developing Countries (Individual) on two consecutive occasions; 2012 and 2014. She serves as the Medical Advisor to the Ghana Haemophilia Society. She is a keen advocate and trainer in blood safety and safe transfusion practices with a special interest in improving survival outcomes in Maternal and Paediatric patients. She has led clinical trials evaluating intervention methods to prevent disease transmission including novel diagnostic approaches and photochemical blood treatment systems to inactivate pathogens and white blood cells in blood products.
Mindy Goldman is the medical director, donor and clinical services at Canadian Blood Services in Ottawa, Ontario. Mindy completed her medical degree at the University of Montreal, and did subsequent training in internal medicine at McGill University in Montreal and hematology and transfusion medicine at McMaster University in Hamilton, Ontario. Mindy is responsible for donor criteria and policies and her current interests include donor health and safety, deferral policies for high risk donor behaviours, and bacterial contamination of blood components. She has been a member of the ISBT Academy and the Rare Donor Working Party and is currently a member of the Haemovigilance Working Party.
Lilian Castilho obtained her Master and PhD degrees at Federal University of São Paulo in Brazil and performed post-doctoral studies in molecular immunohematology at the New York Blood Center, USA. She has worked in laboratories in Brazil and served as consultant for the American Red Cross in Philadelphia, USA. Lilian has experience in the area of immunology, with emphasis on immunohematology and genetics of blood groups. Currently she is a Professor at University of Campinas in Brazil, where she teaches and has an active research laboratory that supports both projects being carried out by graduate and post graduate students and collaborative research projects. She has served on numerous committees and has been the vice-chair of the ISBT working party on Red Cell Immunogenetics and Blood Group terminology.
Birgit Gathof is director of the Transfusion Medicine Unit of the University Hospital of Cologne, Germany. Experience of nine years internal medicine and over 20 years in blood transfusion. Birgit is active in the ISBT Working Party “Clinical transfusion” and co-chair of its subgroup responsible for Patient Blood Management (PBM) educational material. She is also chair of the WP “Hämotherapie” of the German DGTI. Active in the promotion of PBM in the setting of long standing quality assurance in hemotherapy by teaching and the respective explanation and revision of relevant guidelines. Her scientific interests include different aspects of hemotherapy with respect to donor and recipient and product safety and development (pathogenreduction).
Cynthia So-Osman finalized her specialism in Internal Medicine, with a subspecialty training in Haematology (2000) and in Transfusion Medicine (2002). She obtained a Master of Science (MSc) degree in Clinical Epidemiology (2008) and obtained her PhD with a thesis titled: “ Patient Blood Management in Elective Orthopaedic Surgery” in 2012. Since 2002 she is a Clinical Consultant in Transfusion Medicine at Sanquin Blood Bank at the Dept. of Transfusion Medicine, NL, and she actively participates in Patient Blood Management and COVID-19 related studies. As a part-time Haematology Consultant, she works at Erasmus University Hospital, Rotterdam, NL. She chairs the ISBT Clinical Transfusion Working Party, she is a member of the International Collaborative on Transfusion Medicine Guidelines (ICTMG) and a member of the BEST Collaborative.
May Raouf is an haematopathologist with 28 years of experience in clinical and academic aspects of transfusion medicine. She is currently serving as director of the Dubai Blood Donation Centre and coordinator for Emirates Supreme National Blood Transfusion Committee. She is a member of the WHO expert panel for transfusion safety and has served as chairman for the local organizing committee of ISBT's 34th International congress in Dubai. May is also chairing the blood transfusion program in the MedLab Annual Congresses in Dubai and has organized many international scientific meetings with WHO. She has served as medical director and quality manager for internationaly recognized blood banks.
Denese Marks earned her PhD at the University of Technology, Sydney, followed by post-doctoral fellowships at the University of Vienna, the University of Melbourne and the Institute of Child Health at Great Ormond Street Hospital in London, as well as working in the biotechnology industry. Denese is the National Leader for Product Development at Australian Red Cross LifeBlood, where her research focuses on developing new blood products to meet patient needs, improving blood component processing and storage, platelet and red cell cryopreservation, pathogen inactivation and clinical trials of blood products. She is also an adjunct Associate Professor with the University of Sydney School of Medicine. Denese is a Section Editor for Vox Sanguinis, a scientific member of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative and a member of the Executive Committee for the ISBT Cellular Therapies Working Party.
Veera Nadarajan currently holds the positions of Associate Professor at the Department of Pathology, University of Malaya as well as the Head of the Department of Transfusion Medicine at the University Malaya Medical Centre. He has more than 20 years of experience, with diverse research interests that include blood group serology, blood donor care and molecular hematology. He is also actively involved in teaching and training doctors on a national level. Veera sits on several national committees with regards to curriculum developments, specialist accrediation and quality standarts and is also a member of the ISBT Academy.
Mahrukh Getshen has graduated from Grant Medical College, India. She subsequently obtained a diploma in Blood Banking and Transfusion Medicine from Mahidol University, Thailand and a Masters degree in Public Health from Queensland University of Technology, Australia. She heads the National Blood Bank at JDW, National Referral Hospital, Thimphu and also holds a lecturer’s post at KG University of Medical Sciences, Bhutan. In her capacity as the chairperson of National Blood Technical Advisory Committee, she is responsible to provide technical expertise and policy recommendations to the Ministry of Health, Royal Government of Bhutan. Mahrukh Getshen is a member of the World Health Organization Expert Advisory Panel for Blood Transfusion; ICCBBA Board of Directors and Vice-President of the Asian Association of Transfusion Medicine. She is the recipient of the National Order of Merit Award conferred by His Majesty, the King of Bhutan in 2017.